Crystalline polymorphic form 631

Details for Australian Patent Application No. 2010212605 (hide)

Owner AstraZeneca AB

Inventors Bowden, Sharon Ann; Hoile, David Peter; Lovqvist, Karin

Agent Davies Collison Cave

Pub. Number AU-A-2010212605

PCT Pub. Number WO2010/092386

Priority 0902406.8 13.02.09 GB

Filing date 11 February 2010

Wipo publication date 19 August 2010

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

4 August 2011 PCT application entered the National Phase

  PCT publication WO2010/092386 Priority application(s): WO2010/092386

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010212608-Downhole tool

2010212596-Messaging system